TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy. October 1, 1999
TCL Archive Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program July 23, 1999
TCL Archive Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs August 2, 2002
TCL Archive Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development September 13, 1974
TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
